C12Q 2523/30
Reactions characterised by treatment of reaction samples: characterised by physical treatment
Official title: Characterised by physical treatment
C12Q2523/30 (Reactions characterised by treatment of reaction samples: characterised by physical treatment) appears on 59 US grants and 109 published applications in this corpus.
Search patents in C12Q- Granted patents
- 59
- Published applications
- 109
- Assignees
- 83
- Inventors
- 254
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 1 |
| 2010 | 0 | 2 |
| 2011 | 0 | 5 |
| 2012 | 0 | 3 |
| 2013 | 0 | 5 |
| 2014 | 3 | 2 |
| 2015 | 4 | 7 |
| 2016 | 1 | 2 |
| 2017 | 3 | 5 |
| 2018 | 3 | 11 |
| 2019 | 1 | 15 |
| 2020 | 11 | 10 |
| 2021 | 7 | 15 |
| 2022 | 6 | 4 |
| 2023 | 11 | 5 |
| 2024 | 3 | 7 |
| 2025 | 4 | 9 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
- C12Q 2523/313IrradiationIndexing code15
- C12Q 2523/303Applying a physical force on a nucleic acidIndexing code13
- C12Q 2523/319Photocleavage, photolysis, photoactivationIndexing code10
- C12Q 2523/307Denaturation or renaturation by electric current/voltageIndexing code6
- C12Q 2523/305Denaturation or renaturation by physical actionIndexing code5
- C12Q 2523/308Adsorption or desorptionIndexing code4
- C12Q 2523/32CentrifugationIndexing code4
- C12Q 2523/301SonicationIndexing code3
All 9 subgroupsShow fewer
Recent patents
- Device for the analysis of nucleic acid molecules25 Nov 2025US 12,478,964 B2Centre National de la Recherche Scientifique (CNRS)
- Methods of non-destructive nanostraw intracellular sampling for longitudinal cell monitoring16 Sep 2025US 12,416,000 B2The Board of Trustees of the Leland Stanford Junior University
- DNA sequencing with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators17 Jun 2025US 12,331,352 B2The Trustees of Columbia University in the City of New York
- Methods using photothermal nanoparticles in rapid nucleic acid amplification and photothermal nanoparticles18 Feb 2025US 12,227,781 B2Promega Corporation
- Fluorescent polymerase enzyme substrates having protein shields10 Dec 2024US 12,162,903 B2Pacific Biosciences of California, Inc.
- Methods of non-destructive nanostraw intracellular sampling for longitudinal cell monitoring18 Dec 2025US 2025/0382603 A1The Board of Trustees of the Leland Stanford Junior University
- Method of translocating nucleic acids through nanopores16 Oct 2025US 2025/0320543 A1Switchback Systems, Inc.
- Polynucleotide purification with monolith columns21 Aug 2025US 2025/0263687 A1Alexion Pharmaceuticals, Inc.
- Photothermal nanoparticles, devices, and kits3 Jul 2025US 2025/0215473 A1Promega Corporation
- Method of performing a lab developed test22 May 2025US 2025/0163503 A1Gen-Probe Incorporated
Most cited
By later US patents
- Polymerase enzyme substrates with protein shield104US 9,062,091 B2Pacific Biosciences of California, Inc. · 2015
- Enhancing specificity of analyte binding87US 11,702,698 B210x Genomics, Inc. · 2023
- Highly specific circular proximity ligation assay83US 11,530,438 B2The Board of Trustees of the Leland Stanford Junior University · 2022
- Nano-PCR: methods and devices for nucleic acid amplification and detection65US 7,494,791 B2Nanobiosym, Inc. · 2009
- DNA sequence with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators62US 9,115,163 B2The Trustees of Columbia University in the City of New York · 2015